Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Ethnopharmacol ; 155(3): 1500-7, 2014 Sep 29.
Artigo em Inglês | MEDLINE | ID: mdl-25091465

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: A previous pilot ethnobotanical and ethnopharmacological study with the Q'echi׳ Maya identified the family Piperaceae, as an important taxonomic group traditionally used for the treatment of epileptic and culture-bound anxiety disorders and possessing activity in the GABA system. Following that lead, a botanical survey was conducted in Peru, where 47 species of Piperaceae were collected including 21 plants traditionally used for folk illnesses by the Yanesha of Peru, an indigenous Amazonian group. MATERIALS AND METHODS: Two high throughput bioassays were used to quantify the in vitro activity of botanical extracts on the GABA system. RESULTS: Plant extracts demonstrated moderate to high affinity to the γ-aminobutyric acid benzodiazepine (GABA-BZD) receptor. In addition, extracts demonstrated low to moderate activity in the inhibition of the GABA-transaminase, with select plants exhibiting significant activity. Plants indicated by the Yanesha showed comparable activity to the other Piperaceae plants collected. Piper cremii was the most active plant in the GABA-BZD receptor assay, and Drymaria cordata (Caryophyllaceae) in the GABA-T assay. CONCLUSION: The study provides evidence that there is a pharmacological basis behind the use of plants in the treatment of susto and mal aire in both Central and South America, and we propose that the possible mechanism of action includes an interaction with the GABA-T enzyme and/or the GABAA-BZD receptor.


Assuntos
4-Aminobutirato Transaminase/antagonistas & inibidores , Piperaceae , Extratos Vegetais/farmacologia , Receptores de GABA-A/metabolismo , 4-Aminobutirato Transaminase/metabolismo , Bioensaio , Medicina Tradicional , Peru
2.
Neuroscience ; 200: 211-22, 2012 Jan 03.
Artigo em Inglês | MEDLINE | ID: mdl-22079577

RESUMO

Although opiate drugs of abuse have been shown to decrease adult hippocampal neurogenesis, the impact of opiate analgesics has not been tested. North American regulatory boards governing the ethical treatment of experimental animals require the administration of analgesics, such as buprenorphine, following minor surgical interventions. Here, we show that two commonly used post-operative buprenorphine dosing regimes significantly inhibit the proliferation of doublecortin-positive neuroblasts but not other hippocampal stem and progenitor cell populations in adult mice. Buprenorphine, administered in schedules of three 0.05 mg/kg subcutaneous injections over a single day or seven 0.05 mg/kg injections over a 3-day period decreased the number of actively proliferating 5-iodo-2'-deoxyuridine-labeled doublecortin-positive cells for up to 6 days after opiate withdrawal. The minimal (three injection), but not standard (seven injection), analgesic paradigm also reduced basal indices of hippocampal progenitor cell apoptosis and enhanced survival of newly born cells for up to 28 days. Taken together, these data provide the first evidence that the routine administration of opiate analgesics has transient but long-lasting effects on neurogenesis and further emphasize that analgesic dosage and schedule should be reported and considered when interpreting the magnitude of neural stem and progenitor cell activation in response to in vivo intervention.


Assuntos
Células-Tronco Adultas/efeitos dos fármacos , Analgésicos/farmacologia , Buprenorfina/farmacologia , Proliferação de Células/efeitos dos fármacos , Hipocampo/citologia , Neurogênese/efeitos dos fármacos , Análise de Variância , Animais , Antígenos/metabolismo , Bromodesoxiuridina/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Desoxiuridina/metabolismo , Proteínas do Domínio Duplacortina , Proteína Glial Fibrilar Ácida , Hipocampo/efeitos dos fármacos , Marcação In Situ das Extremidades Cortadas , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Proteínas Associadas aos Microtúbulos/metabolismo , Neuroglia/metabolismo , Neuropeptídeos/metabolismo , Fosfopiruvato Hidratase/metabolismo , Proteoglicanas/metabolismo , Fatores de Tempo
3.
Neuroscience ; 167(1): 154-62, 2010 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-20116415

RESUMO

Heterozygous mutations in ClC-2 have been associated in rare cases with increased susceptibility to generalized, idiopathic epilepsy. Initially, it was hypothesized that mutations in ClC-2 may be associated with epilepsy due to a direct role for ClC-2 in the modification of hippocampal neuronal excitability. However, the absence of an overt seizure-susceptibility phenotype in young ClC-2 knockout (KO) mice rendered this hypothesis- implausible. A recent study of older ClC-2 KO mice (>6 months) revealed abnormalities in the myelin of central axons and a subtle defect in the neuronal function in the central auditory pathway. These findings prompted us to re-examine hippocampal neuron morphology and excitability in older ClC-2 KO mice. Interestingly, electrocorticographic recordings obtained in older mice revealed spontaneous interictal spikes which are a marker of perturbed hippocampal neurotransmission with a resultant increase in excitation. This electrophysiological defect was associated with astrocyte activation and evidence of neuronal degeneration in the CA3 region of the hippocampus of these older mice. Together, these findings raise the possibility that ClC-2 expression plays a subtle neuroprotective role in the aging hippocampus.


Assuntos
Envelhecimento , Canais de Cloreto/metabolismo , Hipocampo/fisiopatologia , Degeneração Neural/fisiopatologia , Neurônios/fisiologia , Animais , Astrócitos/fisiologia , Bicuculina/farmacologia , Região CA3 Hipocampal/efeitos dos fármacos , Região CA3 Hipocampal/patologia , Região CA3 Hipocampal/fisiopatologia , Canais de Cloro CLC-2 , Morte Celular/fisiologia , Canais de Cloreto/deficiência , Canais de Cloreto/genética , Eletroencefalografia , Antagonistas GABAérgicos/farmacologia , Hipocampo/efeitos dos fármacos , Hipocampo/patologia , Immunoblotting , Camundongos , Camundongos Knockout , Degeneração Neural/patologia , Neurônios/efeitos dos fármacos , Neurônios/patologia , Picrotoxina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA